Showing results (251-260 of 477) with videos related to
Sort By:
Pageof 48
Neuro-Oncology Advances|April 4, 2024
Plasma ctDNA liquid biopsy of IDH1, TERTp, and EGFRvIII mutations in gliomaJordan J Jones, Hong Nguyen, Stephen Q Wong, et al.Medical Oncology (Northwood, London, England)|April 22, 2016
Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomibZammam Areeb, Stanley S Stylli, Thomas M B Ware, et al.Scientific Reports|October 21, 2020
Reduced EGFR and increased miR-221 is associated with increased resistance to temozolomide and radiotherapy in glioblastomaZammam Areeb, Sarah F Stuart, Alice J West, et al.Stroke|January 20, 2009
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?Stephan A Mayer, Stephen M Davis, Brett E Skolnick, et al.Stroke|June 12, 2004
Insular cortical ischemia is independently associated with acute stress hyperglycemiaLouise E Allport, Ken S Butcher, Tracey A Baird, et al.International Journal of Stroke : Official Journal of the International Stroke Society|August 19, 2008
Aortic arch atheromaJorge A Zavala, Pierre Amarrenco, Stephen M Davis, et al.Stroke|March 15, 2014
Stroke thrombolysis: save a minute, save a dayAtte Meretoja, Mahsa Keshtkaran, Jeffrey L Saver, et al.International Journal of Environmental Research and Public Health|August 25, 2023
Association of Loneliness and Mindfulness in Substance Use Treatment RetentionJohnathan M Herczyk, Keith J Zullig, Stephen M Davis, et al.Epilepsia|June 7, 2014
IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomasSimon V Liubinas, Giovanna M D'Abaco, Bradford M Moffat, et al.The Medical Journal of Australia|April 3, 2003
Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospitalCassandra E I Szoeke, Mark W Parsons, Kenneth S Butcher, et al.Pageof 48